Indianoloa, PA-based Medrad has signed an exclusive two-year agreement to distribute worldwide a cardiovascular MR surface coil developed by W.L. Gore & Associates. The coil combines in a single device a dedicated cardiac coil and a dedicated abdominal
Indianoloa, PA-based Medrad has signed an exclusive two-year agreement to distribute worldwide a cardiovascular MR surface coil developed by W.L. Gore & Associates. The coil combines in a single device a dedicated cardiac coil and a dedicated abdominal coil. Extending from the chest to the bifurcation of the aorta in the pelvic region, the Cardiovascular Array supports the visualization of vascular disease throughout the entire torso in a single scan. The FDA cleared the product, which is compatible with all phased-array versions of the GE Signa 1.5T system and will be available in the U.S. in July. Worldwide distribution will begin next year. Medrad currently distributes another Gore product, the Torso Array surface coil, which was released in November 2000.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.